1. Signaling Pathways
  2. Membrane Transporter/Ion Channel
    Neuronal Signaling
  3. TRP Channel
  4. TRPM4 Isoform

TRPM4

TRPM4 (transient receptor potential melastatin 4) is a Ca2+-activated, voltage-dependent, nonselective monovalent cation channel that converts intracellular Ca2+ signals into membrane depolarization and thereby regulates Ca2+ entry through other Ca2+-permeable pathways[1][2]. Mechanistically, TRPM4 activity is strongly controlled by phosphatidylinositol 4,5-bisphosphate (PIP2), which enhances channel Ca2+ sensitivity, shifts voltage dependence, and counteracts channel desensitization, linking TRPM4 to phospholipase C-associated signaling processes[1]. Through its effects on membrane potential and Ca2+ homeostasis, TRPM4 participates in physiological functions including electrical signaling, immune responses, insulin secretion, and cardiovascular regulation[2][3]. In disease contexts, altered TRPM4 function has been associated with cardiac conduction disorders and other pathophysiological conditions in which dysregulated cellular excitability contributes to disease progression[2]. Compared with the closely related isoform TRPM5, TRPM4 shares the characteristic of being a Ca2+-activated monovalent cation channel but differs in tissue distribution and physiological roles, making isoform-specific interpretation important in experimental studies[3][4]. For experimental applications, pharmacological inhibition of TRPM4 has become a useful strategy for investigating channel-dependent signaling and electrophysiological mechanisms, and several small-molecule inhibitors have been evaluated for their ability to modulate TRPM4 activity in vitro and in vivo[5].

TRPM4 Related Products (4):

Cat. No. Product Name Effect Purity
  • HY-128172
    TRPM4-IN-2
    Inhibitor 99.17%
    TRPM4-IN-2 (NBA) is a potent transient receptor potential melastatin 4 (TRPM4) inhibitor with an IC50 value of 0.16 μM. TRPM4-IN-2 can be used for researching prostate cancer and colorectal cancer.
  • HY-108457
    9-Phenanthrol
    Inhibitor 99.61%
    9-Phenanthrol (9-Hydroxyphenanthrene) is a selective TRPM4 inhibitor with an IC50 of 17 μM. 9-Phenanthrol has no inhibitory activity on TRPM5, TRPC6, and CFTR. 9-Phenanthrol can be used for the research of ischemia-reperfusion injury.
  • HY-153468
    ErSO-TFPy
    Activator 99.33%
    ErSO-TFPy (TEQ103) is an ERα+ tumor cell inhibitor with low nanomolar cytotoxic activity against ERα+ breast cancer cells. ErSO-TFPy activates the sodium channel TRPM4, causes an imbalance of intracellular calcium and sodium ions. ErSO-TFPy dysregulates calcium homeostasis in ERα+ tumor cells, triggers the anticipatory unfolded protein response, and induces rapid immune cell-independent necrotic cell death. ErSO-TFPy can be used for the research of estrogen receptor alpha positive breast cancer.
  • HY-183268
    TRPM4-IN-4
    Inhibitor
    TRPM4-IN-4 (Compound 118) is a selective TRPM4 inhibitor with an IC50 value of 0.339 μM against hTRPM4. TRPM4-IN-4 inhibits hTRPM4 and mTRPM4. TRPM4-IN-4 can be used for the research of colorectal cancer.